Technical Analysis for VXRT - Vaxart, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.61 | 0.36% | 0.00 |
VXRT closed down 1.97 percent on Wednesday, November 20, 2024, on 60 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.36% | |
| Inside Day | Range Contraction | 0.36% | |
| Wide Bands | Range Expansion | 0.36% | |
| Oversold Stochastic | Weakness | 0.36% | |
| New Downtrend | Bearish | -1.61% | |
| Lower Bollinger Band Walk | Weakness | -1.61% | |
| Wide Bands | Range Expansion | -1.61% | |
| Oversold Stochastic | Weakness | -1.61% | |
| Jack-in-the-Box Bearish | Bearish Swing Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Down 3% | about 2 hours ago |
| 60 Minute Opening Range Breakdown | about 2 hours ago |
| Fell Below Previous Day's Low | about 3 hours ago |
| Down 2 % | about 3 hours ago |
| Down 1% | about 3 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/31/2024
Vaxart, Inc., a clinical-stage company, focuses on developing oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company's platform delivers various recombinant protein antigens, such as those used in influenza, hepatitis B, and human papilloma virus (HPV) vaccines, as well as other recombinant vaccines. Its development programs include oral tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus, as well as a therapeutic vaccine for HPV. The company is headquartered in South San Francisco, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Coronavirus Influenza Vaccines Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Human Papilloma Virus Human Papillomavirus Infection Vaccine Preventable Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Coronavirus Influenza Vaccines Hepatitis B Vaccination Papillomavirus Seasonal Influenza HPV Human Papilloma Virus Human Papillomavirus Infection Vaccine Preventable Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.54 |
| 52 Week Low | 0.52 |
| Average Volume | 1,362,518 |
| 200-Day Moving Average | 0.86 |
| 50-Day Moving Average | 0.79 |
| 20-Day Moving Average | 0.71 |
| 10-Day Moving Average | 0.66 |
| Average True Range | 0.05 |
| RSI (14) | 33.33 |
| ADX | 26.37 |
| +DI | 10.86 |
| -DI | 25.55 |
| Chandelier Exit (Long, 3 ATRs) | 0.71 |
| Chandelier Exit (Short, 3 ATRs) | 0.73 |
| Upper Bollinger Bands | 0.86 |
| Lower Bollinger Band | 0.57 |
| Percent B (%b) | 0.13 |
| BandWidth | 40.53 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.0109 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.66 | ||||
| Resistance 3 (R3) | 0.66 | 0.65 | 0.65 | ||
| Resistance 2 (R2) | 0.65 | 0.64 | 0.65 | 0.65 | |
| Resistance 1 (R1) | 0.63 | 0.63 | 0.62 | 0.62 | 0.64 |
| Pivot Point | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 |
| Support 1 (S1) | 0.59 | 0.60 | 0.59 | 0.59 | 0.57 |
| Support 2 (S2) | 0.58 | 0.59 | 0.58 | 0.57 | |
| Support 3 (S3) | 0.56 | 0.58 | 0.56 | ||
| Support 4 (S4) | 0.56 |
